摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 3-(diethylamino)acrylate

中文名称
——
中文别名
——
英文名称
ethyl 3-(diethylamino)acrylate
英文别名
Ethyl 3-diethylaminoacrylate;ethyl 3-(diethylamino)prop-2-enoate
ethyl 3-(diethylamino)acrylate化学式
CAS
——
化学式
C9H17NO2
mdl
——
分子量
171.239
InChiKey
ANTPVARYELNKNQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    12
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    29.5
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis of Novel Ciprofloxacin-Based Hybrid Molecules toward Potent Antimalarial Activity
    摘要:
    Antimalarial drug resistance is a serious obstacle in the persistent quest to eradicate malaria. There is a need for potent chemical agents that are able to act on drug-resistant Plasmodium falciparum populations at reasonable concentrations without any related toxicity to the host. By rational drug design, we envisaged to address this issue by generating a novel hybrid drug possessing two pharmacophores that can act on two unique and independent targets within the cell. We synthesized a new class of ciprofloxacinbased hybrid molecules, which have been integrated with acridine, quinolone, sulphonamide, and cinnamoyl pharmacophores (1-4). We realized a potent chloroquinolone-ciprofloxacin-based antimalarial hybrid (2, CQ-CFX) whose mechanism of action is unlike that of its parent molecules indicating a unique biological target. CQ-CFX is not only potent against CQ-resistant and susceptible strains of Plasmodium falciparum at low nanomolar concentrations (IC50 values are 63.17 +/- 1.2 nM and 25.52 +/- 4.45 nM, respectively) but is also not toxic to mammalian and bacterial systems up to 20 mu M and 1 mu M, respectively.
    DOI:
    10.1021/acsmedchemlett.0c00196
  • 作为产物:
    描述:
    二乙胺丙炔酸乙酯乙腈 为溶剂, 反应 24.0h, 以88.3%的产率得到ethyl 3-(diethylamino)acrylate
    参考文献:
    名称:
    使用双前药/生物有机金属方法增强环丙沙星的抗疟活性
    摘要:
    氟喹诺酮环丙沙星的衍生化通过结合生物有机金属化学和前药方法大大提高了其抗疟活性。发现两种新的非手性化合物2和4对恶性疟原虫对氯喹敏感和对氯喹耐药的菌株的活性比环丙沙星高10到100倍。与环丙沙星相比,这些非手性衍生物杀死寄生虫的速度更快。化合物2和4被证明是有前途的先导,创建了一个新的抗疟药家族。
    DOI:
    10.1021/jm901357n
点击查看最新优质反应信息

文献信息

  • The C=C Bond Decomposition Initiated by Enamine‐Azide Cycloaddition for Catalyst‐ and Additive‐Free Synthesis of <i>N</i> ‐Sulfonyl Amidines
    作者:Xixi Zheng、Jie‐Ping Wan
    DOI:10.1002/adsc.201901054
    日期:2019.12.17
    The chemo‐selective synthesis of N‐sulfonyl amidines is realized via the decomposition of the enamine C=C bond of enaminoesters through an in situ generated triazoline intermediate. Control experiments prove that the electron withdrawing ester group in the enamine component is crucial in inducing the chemo‐selective formation of amidines. The method is featured with high efficiency and sustainability
    N-磺酰基am的化学选择性合成是通过原位生成的三唑啉中间体将烯胺酯的烯胺C = C键分解而实现的。对照实验证明,烯胺成分中的吸电子酯基对于诱导am的化学选择性形成至关重要。该方法以纯水为介质,无需任何催化剂或添加剂,具有高效,可持续的特点。
  • [EN] IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17<br/>[FR] IMIDAZOPYRIDAZINES EN TANT QUE MODULATEURS DE L'IL-17
    申请人:JANSSEN BIOTECH INC
    公开号:WO2021222404A1
    公开(公告)日:2021-11-04
    The present application discloses compounds having the following formula: (I), or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.
    本申请公开了具有以下公式(I)的化合物,或其药用可接受的盐,其中R1、R2、R3、R4和R5在说明书中定义,以及制造和使用所公开化合物的方法,用于治疗或改善IL-17介导的综合征、紊乱和/或疾病。
  • Enhancement of the Antimalarial Activity of Ciprofloxacin Using a Double Prodrug/Bioorganometallic Approach
    作者:Faustine Dubar、Guillaume Anquetin、Bruno Pradines、Daniel Dive、Jamal Khalife、Christophe Biot
    DOI:10.1021/jm901357n
    日期:2009.12.24
    The derivatization of the fluoroquinolone ciprofloxacin greatly increases its antimalarial activity by combining bioorganometallic chemistry and the prodrug approach. Two new achiral compounds 2 and 4 were found to be 10- to 100-fold more active than ciprofloxacin against Plasmodium falciparum chloroquine-susceptible and chloroquine-resistant strains. These achiral derivatives killed parasites more
    氟喹诺酮环丙沙星的衍生化通过结合生物有机金属化学和前药方法大大提高了其抗疟活性。发现两种新的非手性化合物2和4对恶性疟原虫对氯喹敏感和对氯喹耐药的菌株的活性比环丙沙星高10到100倍。与环丙沙星相比,这些非手性衍生物杀死寄生虫的速度更快。化合物2和4被证明是有前途的先导,创建了一个新的抗疟药家族。
  • [EN] IMIDAZOPYRIMIDINES AS MODULATORS OF IL-17<br/>[FR] IMIDAZOPYRIMIDINES EN TANT QUE MODULATEURS DE L'IL-17
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2021220183A1
    公开(公告)日:2021-11-04
    The present application discloses compounds of Formula I or pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, and R5 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.
    本申请公开了化合物I的化学式或其药用盐,其中R1、R2、R3、R4和R5在规范中有定义,以及制备和使用此处公开的化合物的方法,用于治疗或改善IL-17介导的综合症、紊乱和/或疾病。
  • Synthesis of new fluoroquinolones and evaluation of their in vitro activity on Toxoplasma gondii and Plasmodium spp
    作者:G. Anquetin、M. Rouquayrol、N. Mahmoudi、M. Santillana-Hayat、R. Gozalbes、J. Greiner、K. Farhati、F. Derouin、R. Guedj、P. Vierling
    DOI:10.1016/j.bmcl.2004.03.070
    日期:2004.6
    6-amino-3-azabicyclo[3.1.0]hexyl side chain of trovafloxacin. The four compounds are also inhibitory for blood stages of Plasmodium falciparum though at high concentration. These results confirm the potential of quinolones as anti-T. gondii and antimalarial drugs but also show that the QSAR models for T. gondii cannot be reliably extended for screening antimalarial activity.
    描述了四种新的计算机设计的氟喹诺酮的合成,这些合成的氟喹诺酮已通过QSAR分析预测对弓形虫原虫具有活性。这些化合物在体外对弓形虫有抑制作用。这些化合物之一具有与曲伐沙星相当的高活性。它结合了加替沙星或莫西沙星的基本环丙基喹啉结构与托伐沙星的C-7 6-氨基-3-氮杂双环[3.1.0]己基侧链。这四种化合物即使在高浓度下也对恶性疟原虫的血液阶段具有抑制作用。这些结果证实了喹诺酮类药物具有抗T的潜力。刚地和抗疟药,但也表明不能可靠地扩展刚地弓形虫的QSAR模型来筛选抗疟活性。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物